Literature DB >> 26745515

A quantitative study of intracranial hypotensive syndrome by magnetic resonance.

Weizhong Tian1, Ji Zhang2, Jinhua Chen1, Ying Liu3, Xiaoyun Chen1, Ning Wang1.   

Abstract

OBJECTIVES: The study aims to investigate the magnetic resonance imaging (MRI) findings of intracranial hypotension syndrome (IHS) and the change of quantitative indicators, so as to yield a deeper understanding of the disease. PATIENTS AND METHODS: The clinical data and MRI findings of 26 cases of IHS which were confirmed by lumbar puncture were retrospectively analyzed. Two physicians evaluated the MRI findings including thickening and enhancement of dural, pituitary enlargement, subdural effusion (hematocele), venous engorgement and brain sagging, and measured the quantitative indicators including mamillopontine distance and pontomesencephalic angle. The consistency between the two results of the physicians was assessed by Kappa consistency test. The differences of mamillopontine distance and pontomesencephalic angle between the patient group and the control group were determined by paired t-test. The diagnostic efficiency of mamillopontine distance and pontomesencephalic angle was assessed by area under the ROC curve, and their best diagnostic thresholds were also determined, respectively. Age- and sex-matched healthy volunteers controls (n=26) were recruited and served as the control group.
RESULTS: All of the 26 patients suffered from the characterized by orthostatic headache of IHS. The clinical evaluations of dural thickening and enhancement, pituitary enlargement, subdural effusion (hematocele), venous engorgement by the two physicians showed excellent agreements (κ=0.808, 1 and 0.906, P<0.01), and the clinical evaluations of brain sagging showed medium agreements (κ=0.606, P<0.01). The mamillopontine distance and pontomesencephalic angle of the patient group were 5.4 ± 1.6mm and 47.8 ± 8.7°, respectively, which were obviously less than those of the control group (6.9 ± 1.1mm and 61.0 ± 6.1°, respectively), and the differences were statistically significant (t=-4.563, P<0.01; t=-.329, P<0.01). The area under ROC curve of mamillopontine distance and pontomesencephalic angle were 0.774 and 0.908, respectively, and the diagnostic value of pontomesencephalic angle was higher than that of the mamillopontine distance. The sensitivity and specificity were 73.1% and 73.1%, respectively, when diagnostic threshold of mamillopontine distance was 6.4mm. The sensitivity and specificity were 76.9% and 96.2%, when diagnostic threshold of pontomesencephalic angle was 51.7°.
CONCLUSION: The MRI findings presented characteristic features of IHS. The quantitative indicators including mamillopontine distance and pontomesencephalic angle were helpful for clinical diagnosis of subjective findings of IHS.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Intracranial hypotension syndrome; Magnetic resonance imaging; Quantitative assessment

Mesh:

Year:  2015        PMID: 26745515     DOI: 10.1016/j.clineuro.2015.12.014

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  3 in total

1.  Brain Spontaneous Intracranial Hypotension Score for Treatment Monitoring After Surgical Closure of the Underlying Spinal Dural Leak.

Authors:  Tomas Dobrocky; Levin Häni; Roman Rohner; Mattia Branca; Pasquale Mordasini; Sara Pilgram-Pastor; Johannes Kaesmacher; Alessandro Cianfoni; Ralph T Schär; Jan Gralla; Andreas Raabe; Christian Ulrich; Jürgen Beck; Eike I Piechowiak
Journal:  Clin Neuroradiol       Date:  2022-01-14       Impact factor: 3.649

Review 2.  The status of diagnosis and treatment to intracranial hypotension, including SIH.

Authors:  Jin-Ping Lin; Shu-Dong Zhang; Fei-Fang He; Min-Jun Liu; Xiao-Xu Ma
Journal:  J Headache Pain       Date:  2017-01-13       Impact factor: 7.277

3.  Spontaneous Intracranial Hypotension Presenting With Frontotemporal Dementia: A Case Report.

Authors:  Ahmet Ozyigit; Costas Michaelides; Konstantinos Natsiopoulos
Journal:  Front Neurol       Date:  2018-08-17       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.